Novonesis biosolutions for human health – advancing well-being through science-driven innovation
Home
Tate & Lyle to forgo...

Tate & Lyle to forgo shareholder vote on proposed acquisition of CP Kelco

07 Oct 2024 | By Insha Naureen
Revervia
trans